| 5 | 1/1 | 返回列表 |
| 查看: 1418 | 回復(fù): 23 | |||
| 當(dāng)前只顯示滿足指定條件的回帖,點(diǎn)擊這里查看本話題的所有回帖 | |||
ahjxszhh新蟲 (初入文壇)
|
[交流]
My plan to prevent or reverse coronary heart disease(我的終結(jié)冠心病方案) 已有1人參與
|
||
|
My plan to prevent or reverse coronary heart disease(我的終結(jié)冠心病方案) 1.My diea: 1.我的想法: From biological symbiosis evolution environment, find a group of strains. These strains can secrete special enzymes, which are not only resistant to pepsin and trypsin, but also can be absorbed from the intestine into lymph and blood circulation. Then, these enzymes can directly dissolve embolism material, cure and reverse circulatory system embolism diseases and intercellular obstruction diseases, including coronary artery heart disease. Perhaps this way will become a new method of anti-aging. 從生物共生進(jìn)化環(huán)境中找到一組菌株,這些菌株能分泌特殊的酶,這些酶不僅能抵抗胃蛋白酶、胰蛋白酶等,而且能被腸道吸收進(jìn)入淋巴和血液循環(huán),然后能直接溶解栓塞物質(zhì),進(jìn)而治愈和逆轉(zhuǎn)包括冠心病在內(nèi)的循環(huán)系統(tǒng)栓塞性疾病和細(xì)胞間隙阻塞性疾病,這也許是抗衰老的新方法。 2. Differences between my idea and other existing schemes: 2.我的想法與現(xiàn)有其他方案的不同之處: The use of oral absorption of exogenous enzymes directly degrade the obstructive protein and protein complex in human body. 利用外源酶的口服吸收直接降解人體內(nèi)阻塞性蛋白及蛋白復(fù)合物。 3.My plan, targets and timelines 3.我的發(fā)展計(jì)劃、階段性目標(biāo)和時(shí)間線: The 1st 150 days: screening and identification of more than 10 microbial strains; The 2nd 150 days: fermentation, isolation, and purification of enzymes and biochemical identification; The 3rd 150 days: To test the enzymes oral metabolic characteristics (the rate of intestinal absorption); The 4th 150 days: To evaluate the safety and thrombolytic characteristics of enzymes with animal models; The 5th 150 days: Thrombolytic characteristics of the enzymes tested in health volunteers and clinical applications. 第一個(gè)150日:篩選和鑒定10個(gè)以上目標(biāo)菌株;第二個(gè)150日:發(fā)酵、分離、純化酶及生化鑒定;第三個(gè)150日:測(cè)試酶的口服代謝特性(腸道吸收率);第四個(gè)150日:動(dòng)物模型測(cè)試酶的安全性和溶栓特性等;第五個(gè)150日:志愿者測(cè)試酶的溶栓特性及申請(qǐng)臨床。 4. Key words: 4.我的想法的三個(gè)關(guān)鍵詞: biomimetic drugs;enzyme absorbed into blood from the gastrointestinal tract;enzymatic thrombolysis. 5. My particularity: 5.我所具備的特質(zhì): As one of a brave thinker, I insist on long-term observation of nature life, thinking about symbiotic evolution, exploring for the Chinese traditional medicines and the biomimetic drugs. I am good at exploring microbial strains with the special pharmacological functions, oriented to special pharmacology thinking. 我是長(zhǎng)期觀察自然界生物生存、思考共生進(jìn)化、發(fā)掘中醫(yī)藥及探索仿生藥物的勇敢思想者,擅長(zhǎng)于以藥物學(xué)思維導(dǎo)向?qū)ふ野l(fā)現(xiàn)特殊藥理功能的微生物菌株。 6 .Specialties of my team and the division of labor: 6.我的團(tuán)隊(duì)需要的專業(yè)和分工: The research team need zoological researchers in mollusk classification, arthropod classification, microbial researchers in microbial screening, isolation, fermentation, biochemical researchers in enzymatic and biochemical properties, pharmaceutical researchers in microbial and biochemical pharmacy, drug metabolism, medicine effect of drugs, and domestic and foreign intellectual property experts of patent application in microbial strains, drug application of strains, enzyme and gene, drug application of enzyme. 這個(gè)研究團(tuán)隊(duì)需要專業(yè)于軟體動(dòng)物分類、節(jié)肢動(dòng)物分類等動(dòng)物學(xué)研究者、專業(yè)于微生物篩選分離、發(fā)酵等微生物學(xué)研究者、專業(yè)于酶生化特性等生物化學(xué)研究者、專業(yè)于微生物與生化藥學(xué)、藥物代謝、藥物效應(yīng)等藥學(xué)研究者及專業(yè)于菌株、菌株的藥物應(yīng)用、酶及基因、酶的藥物應(yīng)用等國內(nèi)外專利申請(qǐng)的知識(shí)產(chǎn)權(quán)專家。 7. what kinds of organization and partnership I need: 7.我需要什么樣的組織機(jī)構(gòu)和合伙投資人: The organization and the partnership of investors I need should be bio pharmaceutical companies or institutes, professional in microbial screening, fermentation optimization, enzyme separation and purification. The most preferred organization scheme can be venture capital investment in the new set up R & D team. And the project will be implemented by following most of the R & D outsourcing mode. 需要的組織機(jī)構(gòu)和合伙投資人是專業(yè)于微生物篩選、發(fā)酵優(yōu)化和酶分離純化的生物醫(yī)藥公司或研究所等,最優(yōu)選的組織方案可以是新組建研發(fā)團(tuán)隊(duì)加上風(fēng)險(xiǎn)投資,以大部分外包研發(fā)方式實(shí)施項(xiàng)目。 Author: Zhong-hui Shi 作者:施忠輝 Major and hobbies: Entomology, botany, microbiology and pharmacology. 專業(yè)及興趣:昆蟲學(xué)、植物學(xué)、微生態(tài)學(xué)和藥物學(xué)。 Email:325066546@qq.com 網(wǎng)站:http://www.onebraveidea.com/ |
新蟲 (小有名氣)
新蟲 (初入文壇)
|
http://xdrug.dxy.cn/bbs/topic/32884391 5樓說到核心問題了,這個(gè)問題云無心與方舟子PK過。方舟子曾說過“蛋白質(zhì)經(jīng)口服到了腸道,將會(huì)被消化成氨基酸才被人體吸收,通常不能直接進(jìn)入人體發(fā)揮其獨(dú)特作用,所以蛋白質(zhì)藥物(例如胰島素)要注射才有效,口服則無效 ”,注意有“通!倍帧N艺且易匀唤缰袠O為少數(shù)的能被人腸道吸收的酶(但不是胰島素等人內(nèi)源蛋白),從物種種類方面估算,找到菌株的概率為1%,從酶的多樣性上估算,找到目標(biāo)酶的概率為1‰。請(qǐng)看云無心的科普文章:蛋白質(zhì)進(jìn)肚全成氨基酸?讓實(shí)驗(yàn)說話;http://songshuhui.net/archives/43522 ;參考文獻(xiàn)自己找吧。 |
新蟲 (初入文壇)
|
http://xdrug.dxy.cn/bbs/topic/32884391 問題解析: 1、首過效應(yīng):最優(yōu)為耐酸、抗胃蛋白酶、胰蛋白酶等,但也可采用包埋處理的腸溶劑型,減少首過損耗; 2、吸收效率(生物利用度):大分子酶進(jìn)入腸淋巴以及血循環(huán)的效率取決于酶特性,通常武功強(qiáng)于胃、胰蛋白酶、血漿蛋白酶的為優(yōu)選,但還需試驗(yàn)、測(cè)試和篩選; 3、血漿半衰期:抗血漿中的各種蛋白酶,半衰期較長(zhǎng); 4、溶栓特性:就如清洗醫(yī)用器械(如內(nèi)窺鏡官腔)的多酶清洗劑及自動(dòng)循環(huán)清洗機(jī)。優(yōu)選能直接溶栓但不激活內(nèi)源纖溶系統(tǒng),對(duì)形成周期長(zhǎng)且半衰期長(zhǎng)的膠原蛋白、纖維蛋白等能逐漸水解(靶點(diǎn)是血和淋巴循環(huán)中細(xì)胞外的各種蛋白,各種蛋白的生成和降解是動(dòng)態(tài)的,半衰期20秒到1000天不等,如膠原蛋白的半衰期為1000天),在內(nèi)源蛋白降解和生成的安全平衡區(qū)間內(nèi),用藥療程在3-6個(gè)月。酶的化學(xué)反應(yīng)速度遠(yuǎn)快過血液流速,一般不考慮局部用藥; 5、活性高、特異性高、安全性高、治愈率高、作用機(jī)理明確將是其主要特點(diǎn)。 (關(guān)于口服胰島素的亂彈:胰島素有51個(gè)氨基酸,一般腸吸收酶有500個(gè)左右氨基酸,融合不行,整合能行嗎?即使能整合,酶及腸吸收特性又如何?自身會(huì)降解成那些組分?這個(gè)技術(shù)難度極大和未知數(shù)太多!) |
新蟲 (初入文壇)
終于榮獲“民科” “勾直餌咸”的意思是水平太次![]() 答復(fù)13樓的一些參考文獻(xiàn): 這個(gè)領(lǐng)域的研究實(shí)在太少,這篇“科幻”想法被我列在“發(fā)散思維”文件夾中,而且思想試驗(yàn)做了若干次了。因?yàn)椤癉O YOU HAVE AN IDEA BRAVE ENOUGH TO END CORONARY HEART DISEASE?”和“ONE TEAM. ONE VISION. ONE CURE.”(http://www.onebraveidea.com/) 1.Some features of intestinal absorption of intact fibrinolytic enzymeIII-1 from Lumbricus rubellus. 2.Effects of absorption enhancers on intestinal absorption of lumbrokinase. 3.On the pharmacology of bromelain.an update with special regard to animal studies on dose-dependent effects. 4.Gastrointestinal absorption and biological activities of serine and cysteine proteases of animal and plant origin review on absorption of serine and cysteine proteases. 5.Bioavailability of 125I bromelain after oral administration to rats. 6.Absorption of intact peptides studies on transport of protein digests and dipeptides across rat small intestine in vitro. 7.Identification of BACE2 as an avid SZ-amyloiddegrading protease. ....... |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 274求調(diào)劑 +4 | 薛定諤的虎。 2026-04-01 | 4/200 |
|
|---|---|---|---|---|
|
[考研] 食品學(xué)碩362求調(diào)劑 +3 | xuanxianxian 2026-04-01 | 3/150 |
|
|
[考研] 314求調(diào)劑 +4 | 溪云珂 2026-03-26 | 4/200 |
|
|
[考研] 0703化學(xué)/290求調(diào)劑/本科經(jīng)歷豐富/工科也可 +14 | 丹青奶蓋 2026-03-26 | 16/800 |
|
|
[考研] 085600,材料與化工321分調(diào)劑 +5 | 大饞小子 2026-03-27 | 7/350 |
|
|
[考研] 安徽大學(xué)專碩生物與醫(yī)藥專業(yè)(086000)324分,英語已過四六級(jí),六級(jí)521,求調(diào)劑 +10 | 美味可樂雞翅 2026-03-26 | 12/600 |
|
|
[考研] 0855機(jī)械初試280求調(diào)劑 +3 | kazenotori 2026-03-31 | 3/150 |
|
|
[考研] 299求調(diào)劑 +8 | 嗯嗯嗯嗯2 2026-03-27 | 8/400 |
|
|
[考研] 322求調(diào)劑:一志愿湖南大學(xué) 材料與化工(085600),已過六級(jí)。 +10 | XX小鄧 2026-03-29 | 10/500 |
|
|
[考研] 340求調(diào)劑 +4 | 希望如此i 2026-03-31 | 4/200 |
|
|
[考研]
|
小羊36 2026-03-30 | 4/200 |
|
|
[考研] 367求調(diào)劑 +7 | 芋泥啵啵… 2026-03-28 | 7/350 |
|
|
[考研] 吉大生物學(xué)326分求調(diào)劑 +3 | sunnyupup 2026-03-31 | 3/150 |
|
|
[考研] 303求調(diào)劑 +7 | DLkz1314. 2026-03-30 | 7/350 |
|
|
[考研] 279求調(diào)劑 +4 | 蝶舞輕繞 2026-03-29 | 4/200 |
|
|
[考研] 298求調(diào)劑 +4 | 種圣賜 2026-03-28 | 4/200 |
|
|
[考研] 一志愿南京航空航天大學(xué)材料學(xué)碩求調(diào)劑 +3 | @taotao 2026-03-28 | 3/150 |
|
|
[考研] 305求調(diào)劑 +5 | 哇盧卡庫 2026-03-26 | 5/250 |
|
|
[考研] 298調(diào)劑 +3 | jiyingjie123 2026-03-27 | 3/150 |
|
|
[考研] 292求調(diào)劑 +4 | 求求了收下我吧?/a> 2026-03-26 | 4/200 |
|